Clinical verification of body mass index and tumor immune response in patients with breast cancer receiving preoperative chemotherapy

PURPOSE: The body mass index (BMI) is commonly used as a simple indicator of obesity; patients with early-stage breast cancer who are obese (OB) per BMI measurements have been shown to have high postoperative recurrence and low survival rates. On the other hand, it has been shown that lymphocytes pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Takada, Koji, Kashiwagi, Shinichiro, Asano, Yuka, Goto, Wataru, Ishihara, Sae, Morisaki, Tamami, Shibutani, Masatsune, Tanaka, Hiroaki, Hirakawa, Kosei, Ohira, Masaichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529767/
https://www.ncbi.nlm.nih.gov/pubmed/34670511
http://dx.doi.org/10.1186/s12885-021-08857-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529767/
https://www.ncbi.nlm.nih.gov/pubmed/34670511
http://dx.doi.org/10.1186/s12885-021-08857-7

Ejemplares similares